StockNow
Log in
FX/Bonds

AbbVie (ABBV) files for nine-part senior offering; size not disclosed. Plans to use proceeds to fund acquisition of Apogee Therapeutics (APGE)

StockNow breaking-news AI analysis

AbbVie is issuing a nine-part senior offering to fund its $10.9B Apogee acquisition, a strategic move to secure long-acting immunology assets despite near-term EPS dilution.

2 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYGeopolitics

Pakistani sources say Pakistan PM Sharif and Army Chief Munir will visit Saudi Arabia tomorrow, Al Hadath reports

U.S. Economy

US ADP Employment Change (Jul) 44K vs. Exp. 70K (Prev. 98K)